As of early October 2025, drug-resistant bacterial infections, especially those carrying the NDM gene, have surged sharply in the US, with cases rising over fivefold since 2019. Australian researchers developed a new phage therapy targeting Enterobacter infections. In Asia, resistant bacteria cause nearly 80% of newborn sepsis cases, while Kerala, India, faces a deadly outbreak of brain-eating amoeba infections. West Nile virus and mosquito-borne diseases also rise in the US and Europe.